Literature DB >> 21977117

Applicabillity of noninvasive biomarkers in prostate cancer diagnosis.

Raluca Dumache1, Maria Puiu, Dragos Miclea, Bogdan Bumbacila, Florin Miclea.   

Abstract

Prostate cancer represents the second leading cause of male cancer-related deaths worldwide. Better indicators of the presence of prostate cancer are needed to avoid unnecessary treatment, predict disease course and develop more effective therapy. Many molecular biomarkers have been described in human serum, urine, seminal fluid and histological specimens that exhibit varying capacities to detect prostate cancer and predict disease course.

Entities:  

Keywords:  digital rectal examination (DRE); proliferative inflammatory atrophy (PIA); prostate cancer (PCa), benign prostatic hyperplasia (BPH), prostate-specific antigen (PSA), biomarkers; prostatic intraepithelial neoplasia (PIN)

Year:  2010        PMID： 21977117      PMCID： PMC3150079     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN： 1841-9038


  20 in total

1.  Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer.

Authors:  S M Harman; E J Metter; M R Blackman; P K Landis; H B Carter
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

2.  PCA3: a molecular urine assay for predicting prostate biopsy outcome.

Authors:  Ina L Deras; Sheila M J Aubin; Amy Blase; John R Day; Seongjoon Koo; Alan W Partin; William J Ellis; Leonard S Marks; Yves Fradet; Harry Rittenhouse; Jack Groskopf
Journal:  J Urol       Date:  2008-03-04       Impact factor: 7.450

3.  Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis.

Authors:  Shahrokh F Shariat; Dolores J Lamb; Michael W Kattan; Cuong Nguyen; JaHong Kim; Josie Beck; Thomas M Wheeler; Kevin M Slawin
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

4.  Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death.

Authors:  Mark A Rubin; Tarek A Bismar; Ove Andrén; Lorelei Mucci; Robert Kim; Ronglai Shen; Debashis Ghosh; John T Wei; Arul M Chinnaiyan; Hans-Olov Adami; Philip W Kantoff; Jan-Erik Johansson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-06       Impact factor: 4.254

Review 5.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

6.  The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance.

Authors:  Martijn P M Q van Gils; Daphne Hessels; Onno van Hooij; Sander A Jannink; W Pim Peelen; Suzanne L J Hanssen; J Alfred Witjes; Erik B Cornel; Herbert F M Karthaus; Geert A H J Smits; Gerhard A Dijkman; Peter F A Mulders; Jack A Schalken
Journal:  Clin Cancer Res       Date:  2007-02-01       Impact factor: 12.531

Review 7.  DNA alterations in body fluids as molecular tumor markers for urological malignancies.

Authors:  Carsten Goessl; Markus Müller; Bernd Straub; Kurt Miller
Journal:  Eur Urol       Date:  2002-06       Impact factor: 20.096

8.  Methylated genes as new cancer biomarkers.

Authors:  M J Duffy; R Napieralski; J W M Martens; P N Span; F Spyratos; F C G J Sweep; N Brunner; J A Foekens; M Schmitt
Journal:  Eur J Cancer       Date:  2009-01-12       Impact factor: 9.162

Review 9.  The impact of translocations and gene fusions on cancer causation.

Authors:  Felix Mitelman; Bertil Johansson; Fredrik Mertens
Journal:  Nat Rev Cancer       Date:  2007-03-15       Impact factor: 60.716

10.  TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion.

Authors:  Sven Perner; Juan-Miguel Mosquera; Francesca Demichelis; Matthias D Hofer; Pamela L Paris; Jeff Simko; Colin Collins; Tarek A Bismar; Arul M Chinnaiyan; Angelo M De Marzo; Mark A Rubin
Journal:  Am J Surg Pathol       Date:  2007-06       Impact factor: 6.394
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.